跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
induced pluripotent stem cells
首页
药物
induced pluripotent stem cells
induced pluripotent stem cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD
EP 3382008 A1
申请人: FUJIFILM CELLULAR DYNAMICS INC
优先权: 2010
CN
EP
US
WO
11 件公开
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
US 9534205 B2
申请人: SHI YAN
优先权: 2008
EP
US
10 件公开
METHODS FOR CULTURING STEM AND PROGENITOR CELLS
EP 3633024 A1
申请人: MINERVA BIOTECHNOLOGIES CORP
优先权: 2009
CN
EP
US
7 件公开
HUMAN PLURIPOTENT STEM CELLS INDUCED FROM UNDIFFERENTIATED STEM CELLS DERIVED FROM A HUMAN POSTNATAL TISSUE
US 2011039332 A1
申请人: SAKURADA KAZUHIRO
优先权: 2007
EP
US
7 件公开
?? T CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS, AND PRODUCTION METHOD THEREFOR
EP 4289940 A4
申请人: UNIV KOBE NAT UNIV CORP
优先权: 2021
CN
EP
US
WO
6 件公开
Nuclear reprogramming factor and induced pluripotent stem cells
US 2009047263 A1
申请人: UNIV KYOTO
优先权: 2008
US
6 件公开
US 2009227032 A1
申请人: UNIV KYOTO
优先权: 2008
US
2 件公开
US 2010216236 A1
申请人: UNIV KYOTO
优先权: 2010
US
2 件公开
NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
US 2011053244 A1
申请人: OYLER GEORGE A
优先权: 2010
CN
US
5 件公开
USE OF PCBP1 TO GENERATE INDUCED PLURIPOTENT STEM CELLS WHILE INHIBITING ONCOGENESIS
EP 4010471 A4
申请人: IBEX BIOSCIENCES LLC
优先权: 2019
CN
EP
US
WO
4 件公开
NATURAL KILLER CELLS PRODUCED FROM INDUCED PLURIPOTENT STEM CELLS, METHOD FOR PRODUCING SAME, AND USE THEREOF
EP 4506449 A4
申请人: THERABEST CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
PRODUCTION METHOD FOR INDUCED PLURIPOTENT STEM CELLS
EP 4682250 A1
申请人: SEKISUI CHEMICAL CO LTD
优先权: 2023
CN
EP
US
WO
4 件公开
EP 4589004 A1
申请人: SEKISUI CHEMICAL CO LTD
优先权: 2022
CN
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈